Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aprotinin (bovine)
Drug ID BADD_D00158
Description Aprotinin is a protein-based drug that is also known as bovine pancreatic trypsin inhibitor (BPTI). Since it demonstrates the capacity to slow fibrinolysis, it has been employed to reduce bleeding during complex surgery such as heart and liver surgery. For this use, it is typically administered by injection. The goal of using of aprotinin was subsequently to minimize end-organ damage resulting from hypotension due to blood loss in surgery and to reduce the necessity for blood transfusions during surgery. Nevertheless, the drug was formally withdrawn worldwide in May of 2008 after studies confirmed that its use enhanced the risk of complications or death. The substance is consequently made available only for very restricted research use.
Indications and Usage For prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.
Marketing Status Discontinued
ATC Code B02AB01
DrugBank ID DB06692
KEGG ID D02971
MeSH ID D007611
PubChem ID 16130295
TTD Drug ID D08XYX
NDC Product Code 55463-0031
Synonyms Aprotinin | Trypsin Inhibitor, Basic, Pancreatic | Bovine Kunitz Pancreatic Trypsin Inhibitor | BPTI, Basic Pancreatic Trypsin Inhibitor | Kallikrein-Trypsin Inactivator | Inactivator, Kallikrein-Trypsin | Kallikrein Trypsin Inactivator | Kunitz Pancreatic Trypsin Inhibitor | Trypsin Inhibitor, Kunitz, Pancreatic | Basic Pancreatic Trypsin Inhibitor | Bovine Pancreatic Trypsin Inhibitor | Pulmin | Traskolan | Dilmintal | Zymofren | Antilysin | Contrykal | Kontrykal | Kontrikal | Contrical | Iniprol | Trasylol
Chemical Information
Molecular Formula C284H432N84O79S7
CAS Registry Number 9050-74-2
SMILES CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC( C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O) NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O )NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O )NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCC NC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C (NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC (C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC =CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C) C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC= C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Myocardial infarction02.02.02.007; 24.04.04.009--
Myocardial ischaemia24.04.04.010; 02.02.02.008--Not Available
Nausea07.01.07.001--
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Oliguria20.01.03.004--Not Available
Pericardial effusion02.06.01.002--
Pericarditis02.06.02.001--
Peritoneal haemorrhage24.07.02.016; 07.07.02.001--Not Available
Phlebitis24.05.03.001; 12.02.01.002--
Pleural effusion22.05.02.002--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pneumothorax22.05.02.003--
Prothrombin level decreased13.01.02.010--Not Available
Pruritus23.03.12.001--
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pulmonary hypertension24.08.03.002; 22.06.01.001--
Pulmonary oedema02.05.02.003; 22.01.03.003--
Pulmonary thrombosis24.01.06.002; 22.06.02.003--Not Available
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Renal tubular necrosis20.01.07.003--Not Available
Seizure17.12.03.001--
Sepsis11.01.11.003--
Shock24.06.02.002--Not Available
Skin discolouration23.03.03.005--Not Available
Supraventricular tachycardia02.03.03.012--
Tachycardia02.03.02.007--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombophlebitis24.01.02.001--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages